Oncolytics Biotech Inc
(ONCY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Operating Expenses | 3,970 | 3,753 | 3,683 | 2,601 | 2,855 |
| Operating Income | -3,970 | -3,753 | -3,683 | -2,601 | -2,855 |
| Other Income | 41 | 38 | 49 | 47 | 16 |
| Pre-tax Income | -3,928 | -3,715 | -3,634 | -2,553 | -2,839 |
| Income Tax | N/A | N/A | -2 | 0 | 425 |
| Net Income Continuous | -3,928 | -3,715 | -3,632 | -2,553 | -3,264 |
| Net Income | $-3,928 | $-3,715 | $-3,632 | $-2,553 | $-3,264 |
| EPS Basic Total Ops | -0.19 | -0.20 | -0.23 | -0.15 | -0.21 |
| EPS Basic Continuous Ops | -0.19 | -0.20 | -0.21 | -0.15 | -0.21 |
| EPS Diluted Total Ops | -0.19 | -0.20 | -0.23 | -0.15 | -0.21 |
| EPS Diluted Continuous Ops | -0.19 | -0.20 | -0.21 | -0.15 | -0.21 |
| EBITDA(a) | $-3,884 | $-3,648 | $-3,661 | $-2,581 | $-2,839 |